Canopy Growth (CGC) Current Taxes (2021)

Canopy Growth (CGC) posted Current Taxes of $6.1 million for Q4 2021, up 15.15% sequentially from $5.3 million in Q3 2021.

Canopy Growth (CGC) Current Taxes (2021) Analysis & Trends

Canopy Growth has reported Current Taxes for 1 years, with the latest figure at $6.1 million in Q4 2021.

Quarterly Current Taxes changed N/A year-over-year to $6.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $6.1 million (changed N/A YoY) and the FY2021 annual result came in at $10.7 million, changed N/A from the prior year.
Current Taxes improved to $6.1 million in Q4 2021 per CGC's latest filing, from $5.3 million in the prior quarter.
Over five years, Current Taxes peaked at $11.6 million in Q2 2021 and troughed at $5.3 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-355.54 Mn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	138.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	739.89 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	46.00 Mn
10	Canopy Growth	445.49 Mn	198.48 Mn	16.08 Mn	-

Download Data